The largest database of trusted experimental protocols

18 protocols using skf81297 hydrobromide

1

Seizure Behavior Evaluation in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mice were ad random divided over experimental groups. Mice received one of the following treatments 30 min prior to SKF81297 injection: saline, JMV-1843, JMV-2959 (provided by Prof. Fehrentz), or YIL781 hydrochloride (Tocris, Bristol, UK). All drugs were dissolved in 0.9 % (w/v) NaCl (5 mg/kg; body volume of 10 mL/kg) and administered i.p. The D1R agonist SKF81297 hydrobromide (5 mg/kg i.p., Tocris) was dissolved in 0.9 % (w/v) NaCl and administered according to the treatment regimen previously described (Figure 1A) [32 (link)].
After SKF81297 administration, animals were evaluated for behavioral seizures during 45 min and assigned a score based on the following observations: 1 = transient disruption of exploratory behavior by tonic immobility/rigidity; 2 = rearing with forepaw myoclonus; 3 = generalized clonus; 4 = tonic–clonic seizure or rapid jumping and wild running [32 (link)]. All conducting researchers were blinded for treatment.
+ Open protocol
+ Expand
2

Electrophysiology Experiments: Pharmacological Agents

Check if the same lab product or an alternative is used in the 5 most similar protocols
All chemicals used for electrophysiology experiments were obtained from Sigma-Aldrich except D-L-AP5 and NBQX (from Ascent Scientific). The D1 Receptor agonist SKF 81297 hydrobromide (6-chloro-2,3,4,5-tetrahydro-1-phenyl-1H-3-benzazepine hydrobromide) and the D1R antagonist SCH 23390 hydrochloride ((R)-(+)-7chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride) were from Tocris. SKF81297 and SCH23390 were dissolved in water at a 10 mM concentration for stock solutions. Drugs were bath applied for 15 minutes before a “drug recording”.
+ Open protocol
+ Expand
3

Pharmacological Modulation of Neural Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
All drugs were purchased from Sigma Aldrich (St. Louis, MO), or Tocris (Bristol, UK). SKF 81297 hydrobromide (Tocris, 1447) was applied either as puff (500 µM) or flow in (10 µM) depending on experiment type. All other drugs were bath applied: SCH-39166 hydrobromide (Tocris,2299), SCH-23390 hydrochloride (Tocris, 0925), SKF-83566 hydrobromide (Tocris, 1586), Strychnine (Sigma-Aldrich, 8753), Tetraethylammonium chloride (Sigma-Aldrich, 86614), TTX (Tocris Bioscience, 1069), (RS)-CPP (Tocris Bioscience, 0173), NBQX (Tocris Bioscience, 0373), SR 95531 hydrobromide (Tocris Bioscience, 1262), MNI-caged-L-glutamate (Tocris Biosciences 1490), L-741,626 (Tocris Bioscience, 1003), Pyr-3 (Tocris,3753), prazosin (Sigma-Aldrich, P7791), propranolol (Sigma-Aldrich, 40543), and quinpirole hydrochloride (Tocris Bioscience, 1061). For experiments requiring pharmacological agents dissolved in DMSO the concentration never exceeded 0.02% DMSO.
+ Open protocol
+ Expand
4

Neurotransmitter Stock Solution Preparation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Dopamine (DA) hydrochloride (1 M stock, H8602, Sigma-Aldrich), serotonin hydrochloride (50 mM stock, 14332, CAY), and L-adrenaline (epinephrine) (5 mM stock, A0173, TCI) were dissolved in 10 mM HCl. L-noradrenaline bitartrate monohydrate (1 M stock, A0906, TCI), sodium L-glutamate monohydrate (10 mM stock, G0188, TCI), 4-aminobutyric acid (100 mM stock, A0282, TCI), histamine (100 mM stock, 18111–71, Nacalai Tesque), acetylcholine chloride (10 mM stock, A6625, Sigma-Aldrich), R( +)-SCH 23390 hydrochloride (10 mM stock, D054, Sigma-Aldrich), and octopamine hydrochloride (10 mM stock, O0413, TCI) were each dissolved separately in distilled water. SKF 81297 hydrobromide (10 mM stock, 1447, TOCRIS), haloperidol hydrochloride (20 mM stock, 0931, TOCRIS), yohimbine hydrochloride (20 mM stock, 1127, TOCRIS), and tyramine (10 mM stock, A0302, TCI) were dissolved in DMSO. Compound solutions were then subdivided into aliquots and stored at − 20 °C until use. A working solution of 1 M DA was stored at 4 °C for 3 weeks prior to use.
+ Open protocol
+ Expand
5

Dopamine Receptor Agonists Reinstate Cocaine Seeking

Check if the same lab product or an alternative is used in the 5 most similar protocols
Testing conditions were identical to training except the syringe containing sucrose solution was absent. Rats were randomly assigned to drug dose conditions within each experiment. As rats had already been randomly assigned to treatment conditions, this resulted in cohorts of rats (typically 8–12 subjects) each assigned to one of a variety of testing conditions. Drugs were stored at 4 °C in the dark and used within 48 h of preparation. SKF 81297 hydrobromide (Tocris Bioscience, Minneapolis, MN, USA) and (−) quinpirole hydrochloride (R & D Systems, Minneapolis, MN, USA) were dissolved in sterile 0.9 % saline and administered according to body weight (1 ml/ kg) to provide the doses indicated in Figs. 14. Doses were selected from the lowest range of each drug that has been shown to reinstate extinguished cocaine seeking in rats (Self et al. 1996 (link); Alleweireldt et al. 2002 (link)). Rats received handling injections of saline (1 ml/kg) in the vivarium in the afternoon during the 2 days prior to testing. Testing day injections occurred immediately prior to testing in the room containing the operant conditioning chambers. SKF 81297 was administered SC; quinpirole, IP.
+ Open protocol
+ Expand
6

Live-Cell Imaging of GPCR Endocytosis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Live-cell imaging was carried out using Nikon spinning disk confocal microscope with a ×60, 1.4 numerical aperture, oil objective and a CO2 and 37°C temperature-controlled incubator. A 488, 568 nm and 640 Voltran was used as light sources for imaging GFP, mRFP/mApple, and Snap-647 signals, respectively. Cells expressing both Snap-tagged receptor (2 μg) and the indicated nanobody–GFP (200 ng) were plated onto glass coverslips. Receptors were surface labeled by addition of Snap-Cell 647 SiR (1:1000, New England Biolabs) to the media for 20 min, as described previously. Live-cell images where endocytosis was inhibited were carried out by incubating the cells in 30 μM Dyngo 4a (ab120689) at 37°C for 30 min before indicated agonist was added. HEK293 PKA-Cat-GFP knock-in cells were a generous gift from the Huang Lab. Indicated agonists (dopamine hydrochloride [Sigma], SKF81297 hydrobromide [Tocris]) were added and cells were imaged every 20 s for 20 min in DMEM without phenol red supplemented with 30 mM HEPES, pH 7.4. NPEC-caged-dopamine (Tocris) was incubated for 10 min before cells were stimulated with 3.2 μW/cm2 blue light. Time-lapse images were acquired with a CMOS camera (Photometrics) driven by Nikon Imaging Software (NS Elements).
+ Open protocol
+ Expand
7

Dose-Dependent Modulation of Reversal Learning

Check if the same lab product or an alternative is used in the 5 most similar protocols
All drugs were dissolved in saline and injected via the intraperitoneal route. Raclopride (Tocris Bioscience, Bristol, UK) was administered at 0, 0.015, 0.03, and 0.06 mg/kg, 20 min before testing. SCH39166 hydrobromide (Tocris Bioscience) was administered at 0, 0.025, 0.05, and 0.1 mg/kg, 20 min before testing. Note that SCH39166 was chosen for D1R antagonism to avoid off-target effects at the serotonin 5-HT2C receptor, since activity at this receptor affects visual reversal learning (Alsiö et al. 2015 (link)). SKF81297 hydrobromide (Tocris Bioscience) was administered at 0, 0.1, and 0.25 mg/kg, 30 min before testing. (−)-Quinpirole hydrochloride (Sigma-Aldrich, St. Louis, MO, USA) was administered at 0, 0.01, 0.025, 0.1, 0.25, and 0.5 mg/kg, 60 min before testing. A broad dose range of quinpirole was chosen to allow detection of potential differential effects of canonical presynaptic and postsynaptic doses (Eilam and Szechtman 1989 (link)). No adverse reactions to repeated injections were observed in any experiments.
+ Open protocol
+ Expand
8

CAMP Signaling Pathway Modulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
8-(4-chlorophenylthio) adenosine-3’,5’-cyclic monophosphate (8-CPT-cAMP) was purchased from BIOLOG Life Science Institute. The inhibitors 9-(tetrahydro-2-furanyl)-9H-purin-6-amine (SQ22536), 1,4-diamino-2,3-dicyano-1,4-bis[2-aminophenylthio]butadiene (U0126), N-[2-[[3-(4-bromophenyl)-2-propenyl-]amino]ethyl]-5-isoquinolinesulfonamide dihydrochloride (H-89), and α-[amino[(4-aminophenyl)thio]methylene]-2-(trifluoromethyl)benzeneacetonitrile (SL327), and D1 receptor ligands SKF81297 hydrobromide and SCH-23390 hydrochloride were purchased from Tocris. Reserpine and phorbol 12-myristate 13-acetate (PMA) were obtained from Sigma. Drug stocks were prepared at 50 or 100 mM in DMSO, followed by dilution in culture media to final concentrations of 100 μM 8-CPT-cAMP, 10 μM Reserpine, 10 μM U0126, 30 µM H89, 1 mM SQ22536, 10 µM SCH-23390, 10 µM SKF 81297, and 100 nM PMA.
+ Open protocol
+ Expand
9

Dopaminergic Signaling Modulation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
CNO (Tocris) was first diluted in DMSO (Sigma), then in Dulbecco’s Phosphate Buffered Saline (PBS, Gibco) to a 0.5% DMSO final concentration and injected intraperitoneally at 3 mg/kg 15 min before behavioral testing. Dopamine hydrochloride (Tocris, #3548), SKF81297 hydrobromide (Tocris, #1447) and (−)-Quinpirole hydrochloride (Tocris, #1061) were diluted in ACSF (see below) to respectively 10, 50 and 10 µM, extemporaneously for each day of recording, and kept protected from light for the duration of the bath perfusion.
+ Open protocol
+ Expand
10

Pharmacological Modulation of Acute Slicing

Check if the same lab product or an alternative is used in the 5 most similar protocols
For acute slicing experiments, drugs were applied via bath perfusion as previously described73 (link). Final concentrations are indicated in parentheses: (+)-muscarine-iodide (10 μM) and SKF 81297 hydrobromide (1 μM) were obtained from Tocris. FSK (50 µM) was obtained from either Tocris or Cayman Chemicals.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!